Epigenetics Market size is set to grow by USD 1.47 billion from 2024-2028, Rising epigenetic applications in non … – PR Newswire

NEW YORK, May 24, 2024 /PRNewswire/ --The globalepigenetics marketsize is estimated to grow by USD 1.47billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 14.75% during the forecast period.

For more insights on the forecast market size and historic data (2018 - 2022)-Download Free sample report in minutes

Forecast period

2024-2028

Base Year

2023

Historic Data

2018 - 2022

Segment Covered

Application (Oncology and Non-oncology), Product (Reagents, Kits, and Enzymes and others), and Geography (North America, Europe, Asia, and Rest of World (ROW))

Region Covered

North America, Europe, Asia, and Rest of World (ROW)

Key companies profiled

Abcam plc, Active Motif Inc., Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., Eisai Co. Ltd., Element Biosciences Inc, EpiGentek Group Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Novartis AG, Pacific Biosciences of California Inc., PerkinElmer Inc, Promega Corp., QIAGEN NV, Thermo Fisher Scientific Inc., Zymo Research Corp., and CellCentric Ltd.

Key Market Trends Fueling Growth

The epigenetics market is experiencing significant growth due to the rising prevalence of chronic diseases and the demand for personalized medicine. Enzyme technology, including production, isolation, purification, and utilization of enzymes for synthetic drug assembly, is a key driver. Researchers modify enzyme properties for desired functions like kinetics, thermal stability, and specificity, which are essential for gene expression studies.

This technology is also utilized in pharmaceuticals for treating spinal injuries, nerve tissue regeneration, and SCID. Epigenetics is also linked to various health issues such as cancer, neurological disorders, and autoimmune diseases. Key areas of focus include DNA methylation, epigenetic markers, and non-oncology conditions. Technological advancements in toxicoepigenetics, artificial intelligence (AI), and machine learning (ML) further expand market opportunities.

MarketChallenges

Research report provides comprehensive data on impact of trend, driver and challenges-Download Free sample report in minutes

Segment Overview

1.1Oncology- The epigenetics market experiences substantial growth in the healthcare sector, particularly in the oncology segment. Epigenetic processes, such as DNA methylation and histone modification, play a crucial role in various diseases, including cancers. Cancers can be caused by a multitude of factors, including viruses, aging population, and exposure to causative agents like cigarette smoke, heavy metals, and pesticides.

Epigenetic testing, through assays like methylation-specific PCR (MSP), aids in identifying abnormalities in DNA methylation patterns, helping diagnose diseases such as breast cancer, cervical cancer, liver cancer, and lung cancer. Epigenetic testing also holds potential for non-oncology conditions, such as autoimmune diseases and reproductive problems.

Affordability, approvals, and funding are essential factors influencing the market's growth. Instruments, kits, enzymes, RNA regulation, and services are integral components of the epigenetics market. Epigenetic processes are influenced by external stimuli, including hormones and radiation, further expanding the market's scope.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2018 - 2022) - Download a Sample Report

Research Analysis

The Epigenetics Market encompasses a significant and growing sector in the healthcare industry. This market focuses on the study of Epigenetic pathways, which involve modifications to DNA methylation and histone proteins, influenced by various causative agents such as external stimuli, autoimmune diseases, cigarette smoke, heavy metals, and pesticides.

Epigenetic testing and Epigenetic products play a crucial role in understanding the control of genes in various ailments, including autoimmune diseases, breast cancer, cervical cancer, and chronic diseases. Epigenetics offers insights into the causative agents of cognitive function impairments and reproductive problems. The Epigenetics Market continues to expand as research advances in understanding the intricacies of Epigenetic modifications and their implications for various cancers and diseases.

Market Research Overview

The Epigenetics Market refers to the industry focused on the study of epigenetic modifications, which alter gene expression without changing the DNA sequence. These modifications play a crucial role in various biological processes, including development, aging, and disease. The market encompasses technologies and tools used for epigenetic research, such as chromatin immunoprecipitation, bisulfite sequencing, and massively parallel sequencing.

Epigenetic modifications are linked to numerous diseases, including cancer, neurological disorders, and metabolic conditions. The market is driven by the growing understanding of the role of epigenetics in health and disease, as well as advancements in technologies for studying these modifications. Additionally, the increasing demand for personalized medicine and diagnostics is expected to fuel market growth.

Table of Contents:

1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation

7Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email:[emailprotected] Website:www.technavio.com/

SOURCE Technavio

See original here:
Epigenetics Market size is set to grow by USD 1.47 billion from 2024-2028, Rising epigenetic applications in non ... - PR Newswire